Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
03/2001
03/14/2001EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001US6201013 Inosine monophosphate dehydrogenase (impdh) inhibitor; side effect reduction, non-drug resistant
03/13/2001US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity
03/13/2001US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics
03/13/2001US6200976 Antithrombotic quinoxazolines
03/13/2001US6200967 Used as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders
03/08/2001WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function
03/08/2001WO2001002367A3 Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
03/08/2001WO2000050872A3 A system for cell-based screening
03/08/2001WO1999039704A8 Antibacterial agents
03/07/2001EP1081142A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
03/07/2001EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
03/07/2001EP1080074A1 New heterocyclically substituted amides, their production and their use
03/07/2001EP1079821A1 Protease inhibitors
03/07/2001EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders
03/07/2001EP0641325B1 Retroviral protease inhibitors
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197771 Nervous system disorders; antiischemic agents; alzheimer'sdisease; parkinson's disease; huntington's disease
03/06/2001CA1341196C Process for the preparation of substituted imino diacids
03/01/2001WO2001014879A1 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof
03/01/2001WO2001014328A2 Substituted ureas as cell adhesion inhibitors
03/01/2001WO2001014320A1 Compounds that inhibit tryptase activity
03/01/2001DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity
03/01/2001CA2381096A1 Compounds that inhibit tryptase activity
02/2001
02/28/2001EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
02/28/2001EP1077945A1 Isoquinolines as urokinase inhibitors
02/28/2001EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
02/28/2001EP1077698A1 Metabolites of ecteinascidin 743
02/28/2001CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/27/2001US6194409 Heterocyclic derivatives and their use as antithrombotic agents
02/22/2001WO2000071500A8 Halogen compounds
02/21/2001EP1076649A1 Isoquinoline compound melanocortin receptor ligands and methods of using same
02/21/2001CN1284946A Substituted isoquinoline derivatives and their use as anticonvulsants
02/21/2001CN1062266C Amidine derivative and platelet agglutination inhibitor containing said amidine derivative
02/15/2001WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001WO2001010839A2 Multivalent substituted ketoamides and amides for treating hair loss
02/15/2001WO2001010838A1 Multivalent compounds
02/15/2001WO2001010835A1 Antibacterial agents
02/15/2001WO2001010834A2 Antibacterial agents
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/14/2001CN1283995A Antiviral compounds
02/13/2001US6187789 Muscle relaxants for emergency intubation and surgery
02/08/2001WO2001009101A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance
02/08/2001WO2001009100A1 Reductive methylation of tetrahydroisochinoline in a static micromixer
02/08/2001WO2001009065A2 Nitration in a static micromixer
02/07/2001EP1074545A1 Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient
02/07/2001EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
02/07/2001EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors
02/07/2001EP0922035B1 Tetrahydroisoquinoline derivatives and their pharmaceutical use
02/07/2001CN1282738A Improved method for sgnthesizing 6,9-bis[(2-aminoethyl) amino] benz[g] isoquinoline-5, 10-diketone and its dimaleate
02/07/2001CN1282732A 'alpha'-hydroxy-'beta' amino acid ester and its preparation method
02/01/2001WO2001007412A1 Antiviral tetrahydroisichinolinsulfonamides
02/01/2001DE19935694A1 Reduktive Methylierung von Aminen im statischen Mikromischer Reductive methylation of amines in the static micromixer
02/01/2001DE19935692A1 Nitrierung in einem statischen Mikromischer Nitration in a static micromixer
01/2001
01/31/2001EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
01/31/2001EP1072263A1 Amide derivatives and nociceptin antagonists
01/31/2001EP1071669A1 Bicyclic compounds having an anti-thrombitic effect
01/30/2001US6180675 IL-8 receptor antagonists
01/30/2001US6180646 Retroviral protease inhibitors
01/30/2001US6180645 Antiepilepic agent
01/30/2001US6180619 Prenyl transferase inhibitors
01/25/2001WO2001005783A1 Bradykinin b1 receptor antagonists
01/25/2001DE19934272A1 New N-phenyl-tetrahydroisoquinoline-sulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
01/25/2001CA2379064A1 Bradykinin b1 receptor antagonists
01/24/2001EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
01/24/2001EP1069901A1 Calcilytic compounds and method of use
01/24/2001CN1281362A Novel combination medicine
01/23/2001US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers
01/18/2001WO2001004090A2 Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
01/18/2001WO2001004087A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments
01/17/2001EP1069110A1 Sulfonamide derivatives
01/17/2001EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001EP0725059B1 2,3-diaminopropionic acid derivative
01/16/2001US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound
01/11/2001WO2001002368A1 N-heterocyclic derivatives with neuronal activity
01/11/2001WO2001002367A2 Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
01/11/2001WO2001002366A2 Substituted isoquinoline derivatives and their use as inticonvulsants
01/11/2001CA2527931A1 Substituted isoquinoline derivatives and their use as anticonvulsants
01/11/2001CA2376495A1 Substituted isoquinoline derivatives and their use as anticonvulsants
01/04/2001WO2001000573A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
01/04/2001WO2001000206A1 Vla-4 inhibitor compounds
01/04/2001CA2377087A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
01/04/2001CA2369308A1 Vla-4 inhibitor compounds
01/03/2001EP1065200A1 Aminoisoquinoline derivatives
01/03/2001CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity
01/03/2001CN1278793A Sulfonyl derivatives
01/02/2001US6169088 1,3 diazines with platelet-derived growth factor receptor inhibitory activity
01/02/2001US6169085 A viricide for preventing and treating retroviral infection or the spread of a retrovirus, inhibiting replication of a retrovirus and treating aids
01/02/2001US6168776 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
12/2000
12/28/2000WO2000078145A1 Macrophage scavenger receptor antagonists
12/28/2000DE19929076A1 New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
12/28/2000CA2377288A1 Macrophage scavenger receptor antagonists
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
12/27/2000CN1278250A Vitronectin receptor antagonists
12/27/2000CN1059902C Estrogen excitant/antagonist
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 119